GKWIM
TXG icon

Gerber Kawasaki Wealth & Investment Management’s 10x Genomics TXG Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-55
Closed -$8K – 1046
2021
Q3 		$8K Buy
+55
New +$9.44K ﹤0.01% 687

Other funds holding TXG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's TXG Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of 10x Genomics (TXG) in Q4 2021, closing a stake of 55 shares — an estimated $8K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in TXG in Q3 2021 and held it in 1 quarter. The position peaked at $8K in Q3 2021. 365 funds tracked by Wall St. Rank hold TXG as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining 10x Genomics position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 55 10x Genomics shares in Q4 2021, an estimated $8K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in 10x Genomics in Q3 2021 and held it in 1 quarter.
  • Gerber Kawasaki Wealth & Investment Management's 10x Genomics position peaked at $8K in Q3 2021.
  • 365 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.